Patient Guide: A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 300 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06417814
Status: 🟢 Enrolling Now
Condition: Metastatic Non-small Cell Lung Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 300 locations across the country.

Top locations include:
  • • Fayetteville, Arkansas
  • • Duarte, California
  • • Fountain Valley, California
  • • And 297 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Join Clinical Trial NCTNCT06417814

How to Join This Clinical Trial - NCTNCT06417814

Learn how to participate in this PHASE3 trial studying an investigational therapy for Metastatic Non-small Cell Lung Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Non-small Cell Lung Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Non-small Cell Lung Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06417814 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 300 locations. Find a study site near you:

Clinical Research Site

Fayetteville, Arkansas 72703 - United States

Status: RECRUITING

Clinical Research Site

Duarte, California 91010 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Fountain Valley, California 92708 - United States

Status: RECRUITING

Clinical Research Site

La Jolla, California 92093 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90048 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

San Diego, California 92123 - United States

Status: SUSPENDED

Clinical Research Site

Colorado Springs, Colorado 80909 - United States

Status: RECRUITING

Clinical Research Site

Fort Collins, Colorado 80528 - United States

Status: RECRUITING

Clinical Research Site

Gainesville, Florida 32608 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Jacksonville, Florida 32256 - United States

Status: RECRUITING

And 290 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Metastatic Non-small Cell Lung Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships